Welcome to our dedicated page for Veradigm news (Ticker: MDRX), a resource for investors and traders seeking the latest updates and insights on Veradigm stock.
Veradigm Inc. (MDRX) is a healthcare technology company that focuses on healthcare data and technology solutions for providers, payers, and biopharma organizations. News about Veradigm often centers on how the company uses its platforms, data, connectivity, and expertise within the Veradigm Network to support clinical, operational, and financial performance in healthcare.
Investors and industry observers following MDRX news can expect updates on business performance, financing, and capital structure, as reflected in Veradigm’s announcements about financial outlooks, cash and debt levels, and debt financing arrangements. The company also issues news about its progress on financial reporting, including the filing of its Annual Report on Form 10-K with restated financial statements and its efforts to become current in SEC filings and pursue relisting on a national stock exchange.
Operational and client-focused news includes case studies and collaborations that highlight Veradigm’s role in value-based care, payer–provider integration, and revenue cycle management. Examples include recognition through a KLAS Points of Light Award for delivering insights at the point of care and announcements about organizations selecting Veradigm Revenue Cycle Services, Coding Services, and related offerings such as Veradigm Revenue Analytics, Veradigm Practice Management, and Veradigm Payerpath.
Veradigm also issues news on product and capability developments, such as applying artificial intelligence to deidentified EHR data to generate real-world evidence for GLP-1 therapies, and on thought leadership initiatives like the Smart Medicine Podcast. Governance and corporate updates, including leadership appointments and amendments to the company’s stockholder rights plan, are additional recurring themes. For a comprehensive view of MDRX-related developments, this news page aggregates these announcements and related coverage in one place.
Allscripts announced that its business unit, Veradigm, received the 2015 ONC Health IT Update Certification for its EHR platform. This certification confirms that Veradigm EHR complies with federal reporting requirements and the latest 21st Century Cures Act regulations, ensuring eligible clinicians can participate in quality programs. Veradigm EHR aims to support independent physician practices with advanced technology, improving patient care and practice profitability. Allscripts aims to enhance healthcare outcomes through its integrated solutions.
Allscripts Healthcare Solutions (MDRX) reported third quarter 2022 consolidated revenue of $152 million, a 4.8% increase from $145 million in Q3 2021. Veradigm revenue reached $145 million, up from $137 million year-over-year. Operating profit rose over 30% to $25 million, though GAAP net income dipped slightly to $15 million from $16 million. Non-GAAP diluted earnings per share were $0.23, up from $0.21 in the prior year. The company affirms a 2022 outlook with Veradigm revenue growth expected between 6% to 7% and free cash flow forecasted at $110 million to $120 million.
Allscripts Healthcare Solutions (NASDAQ: MDRX) will announce its financial results for Q3 2022 after the market closes on November 3, 2022. A conference call to discuss the earnings will follow at 4:30 p.m. ET. The announcement will be immediately available on the Allscripts investor relations website. Participants can join the call by dialing 877-269-7756 or 201-689-7817 with Conference ID # 13733727. A replay will be accessible for one year on the investor relations site.
Thomas H. Lee Partners announced the appointment of Paul Black as a consultant for its healthcare investment group. With over 25 years in healthcare IT, Black will assist in identifying and growing investment opportunities. His past roles include CEO of Allscripts (MDRX) and COO of Cerner (CERN). Shahab Vagefi, Managing Director at THL, emphasized Black's experience will enhance their strategy focused on healthcare technology investments. THL has raised over $34 billion and has a history of successful healthcare investments.
Allscripts Healthcare Solutions (NASDAQ: MDRX) will hold a virtual Investor Day on September 28, 2022, at 12:00 p.m. Eastern. The event features presentations from the executive management team and includes a Q&A session. Interested participants can register for the webcast or dial-in via provided links. Presentation slides will be available at approximately 11:30 a.m. Eastern that day on the Allscripts Investor Relations website. A replay will be accessible three hours post-event for six months. For information, visit www.allscripts.com.
Veradigm, a healthcare data and technology solutions provider and a unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), has announced a new agreement with Vytalize Health, a Medicare ACO. This collaboration will see Vytalize Health's solutions integrated into the Practice Fusion EHR, enhancing value-based care for primary care physicians. The aim is to improve patient outcomes and reduce healthcare costs through personalized care plans and clinical support. This partnership positions Veradigm at the forefront of the shift toward value-based care in the U.S.
Summary not available.
Veradigm, a unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), has been ranked #1 in Black Book's 2022 survey for Ambulatory Claims Management and Clearinghouse Solutions. Veradigm Payerpath is recognized for its robust revenue cycle management capabilities, achieving a first-pass clean claims rate exceeding 98% and interfacing with over 3,100 payers. This award highlights Veradigm's commitment to improving healthcare connections and enhancing practice profitability. The Black Book ranking emphasizes operational excellence across 18 performance areas, based on user feedback.
Allscripts Healthcare Solutions (MDRX) reported a 10% increase in year-to-date bookings, totaling $172 million. The second quarter of 2022 saw revenues of $151 million, up from $141 million in 2021. Veradigm's revenue rose to $145 million, a gain from $133 million YoY. Despite a GAAP loss from operations of $5 million, adjusted EBITDA improved to $39 million. The company affirms its financial outlook for 2022, projecting 6-7% revenue growth and free cash flow between $110-120 million. Stock repurchases amounted to $94 million in Q2.
Allscripts Healthcare Solutions (NASDAQ: MDRX) is set to report its financial results for Q2 2022 on August 4, 2022, after market close. The announcement will include details on the earnings call scheduled for 4:30 PM ET the same day. The earnings announcement will be available on Allscripts' investor relations website. Investors can join the call via phone or through the website. A replay will be accessible for six months post-call.